Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre

Autor: Syed Nabil, Hui Yuh Soh, Abd Jabar Nazimi, Roszalina Ramli, Benjie Law, Rama Krsna Rajandram
Jazyk: angličtina
Rok vydání: 2021
Předmět:
medicine.medical_specialty
bisphosphonate
PRP
Osteoradionecrosis
medicine.medical_treatment
ORN
platelet-rich fibrin
MRONJ
lcsh:Technology
Fibrin
lcsh:Chemistry
03 medical and health sciences
0302 clinical medicine
jaw
medicine
osteoradionecrosis
General Materials Science
Autologous platelet
Instrumentation
lcsh:QH301-705.5
Fluid Flow and Transfer Processes
biology
business.industry
lcsh:T
Process Chemistry and Technology
osteonecrosis
General Engineering
Soft tissue
L-PRF
030206 dentistry
Bisphosphonate
medicine.disease
Platelet-rich fibrin
Adjunct
lcsh:QC1-999
Computer Science Applications
Surgery
lcsh:Biology (General)
lcsh:QD1-999
Sequestrectomy
lcsh:TA1-2040
030220 oncology & carcinogenesis
biology.protein
business
lcsh:Engineering (General). Civil engineering (General)
lcsh:Physics
PRF
Zdroj: Applied Sciences
Volume 11
Issue 8
Applied Sciences, Vol 11, Iss 3365, p 3365 (2021)
ISSN: 2076-3417
DOI: 10.3390/app11083365
Popis: Osteoradionecrosis (ORN) of the jaws and medication-related osteonecrosis of the jaws (MRONJ) are uncommon but serious diseases affecting the oral and maxillofacial region with clinically similar appearance but distinct pathophysiology. Management of ORN and MRONJ is inherently challenging and the treatment outcomes are unpredictable. The use of autologous platelet concentrates (APCs) to promote hard and soft tissue healing is well described in the literature, and the efficacy of leucocyte and platelet-rich fibrin (L-PRF) has been well documented in a number of clinical studies. The aim of this study was to present our treatment strategy and the outcomes of incorporating L-PRF as a surgical adjunct in management of ORN and MRONJ in our centre. Methods: eight cases of ORN and MRONJ were treated with a combination of sequestrectomy and L-PRF as a surgical adjunct. Results: the overall success was 87.5%. Using L-PRF as an adjunct, we were able to predictably manage ORN and MRONJ without causing significant morbidity. Conclusion: our experience shows that L-PRF may be used as a valuable and cost-effective adjunct to surgical management of ORN and MRONJ. However, due to a limited number of patients, and a short period of review, the true effectiveness of the method is yet to be demonstrated in a longer follow-up study including a greater number of patients, besides the inclusion of a control group.
Databáze: OpenAIRE